Carregant...
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
An intramuscular formulation of onabotulinumtoxinA (onabotA; Botox(®)) is currently the only therapy specifically approved for the prevention of headaches in adults with chronic migraine (CM) in the EU and North America. This article provides a narrative review of relevant data on the drug in this i...
Guardat en:
| Publicat a: | Drugs |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5915521/ https://ncbi.nlm.nih.gov/pubmed/29532439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-018-0894-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|